Scientific Sessions
Scientific Sessions
  • Program
  • #AHA24
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Resources
  • Program
  • #AHA24
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Nov 13th, 2021

Sunday's Industry Events | Learning Studios and Symposia


Newsletter Card Combination

6-7:30 a.m. EST

-   Screening and Management of Chronic and Diabetic Kidney Disease: How Does Your Approach Compare With the Experts?

9:30-10:15 a.m. EST

-      Implementing GDMT in Worsening Heart Failure Patients – Easy or Challenging? A Debate

-       Add on Efficacy. Oral, Nonstatin Therapies for Lowering LDL-C

11-11:45 a.m. EST

-       Clinical Insights in NVAF: Reducing the Risk of Stroke and Systemic Embolism

-       Double Trouble: AF & HF

-       Cholesterol Efflux Hypothesis: Rethinking Good Cholesterol

12:15-1 p.m. EST

-       The Journey to Diagnosis: Recognizing the Signs and Symptoms of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

-       Diagnosing Aortic Stenosis in Women to Close the Treatment Gap

-      Evolving the Chronic Heart Failure Treatment Paradigm in Cardiology

3:30-4:15 p.m. EST

-       VASCEPA® (icosapent ethyl): Elevating the Standard of Care

5-6 p.m. EST

-     Improving the Detection and Management of Cardiac Immune-Related Adverse Events in Patients With Cancer Is a Must: Are You Prepared?

5-6:30 p.m. EST

-     Updates in Heart Failure: From Definition to Treatments and Everything In-Between

7:30-9 p.m. EST

-    Clinical Run Down: 3 Hot Topic Sessions on ASCVD Risk Reduction

-    Hidden in Plain Sight: ATTR CM in Overlooked Patient Populations

These events are not part of the official Scientific Sessions 2021 as planned by the AHA Committee on Scientific Sessions Program. 

Visit Scientific Sessions Conference Coverage for more articles.

 

Interesting Stories
Lp(a) and Peripheral Artery Disease Toolkit
Sponsored by Kaneka Corporation
Lp(a) and Peripheral Artery Disease Toolkit
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
Sponsored by Medscape
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
Screening for Kidney Disease to Reduce CVD Risk
Sponsored by Bayer
Screening for Kidney Disease to Reduce CVD Risk
Unmet Needs in Hypertension Toolkit
Sponsored by Medtronic
Unmet Needs in Hypertension Toolkit
More Content
Getty Images 1180201381
Daily Coverage
Join the Scientific Sessions 2022 Scavenger Hunt
Aug 15th, 2022
Live Meeting Image
AHA21
Member Connect
Dec 13th, 2021
P104 Steven Botts Image
AHA21
Members Connect: ERG Governs Chromatin Accessibility in Aortic Endothelial Cells
Dec 13th, 2021
Pres Address Lloyd Jones2
AHA21
Watch: #AHA21 recap and look ahead
Nov 22nd, 2021
Getty Images 1301907602
AHA21
Mark your calendar for #AHA22
Nov 19th, 2021
Elaine Hylek, MD, MPH, and Bruno Caramelli, MD, PhD
AHA21
Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption
Nov 19th, 2021
Lbs02 Group Blood Patel
AHA21
Update on local and global hypertension science
Nov 19th, 2021
Getty Images 1219980553 61849bc953192
AHA21
Read all about #AHA21 in your daily coverage
Nov 16th, 2021
(from left to right): Brahmajee K. Nallamothu, MD, MPH, FAHA, Rhoda Au, PhD, Seth Martin, MD, MHS, FAHA, and Andrea Beaton, MD, FAHA
AHA21
QCOR at Sessions: mHealth strategies could help treat CVD around the world
Nov 15th, 2021
(from left to right, top to bottom rows): Corey E. Ventetuolo, MD, MS, Magdi Yacoub, OM, FRS, Karen Joynt Maddox, MD, MPH, FAHA, Gregory Lewis, MD, Marco Guazzi, MD, PhD, FAHA, Ana Macumbi, MD, PhD, FESC, Mark T. Gladwin, MD, FAHA, and William Bain, MD
AHA21
The shifting profile of cardiopulmonary COVID-19 survivors
Nov 15th, 2021
(from left to right): Jonathan P. Piccini, MD, MHS, FAHA, and Steven A. Lubitz, MD, MPH, FAHA
AHA21
Late-Breaking Science: New information in cardiac disease
Nov 15th, 2021
(from left to right): Nasrien E. Ibrahim, MD, Stefan D. Anker, MD, PhD, and Clyde W. Yancy, MD, MSc, FAHA
AHA21
The latest science in heart failure
Nov 15th, 2021